                                  DC REGULATIONS

DEFINITIONS (ยง 29-2099)

2099.1. For purposes of this chapter, the following terms shall have the
   meanings ascribed:
   
   
   
   Department &#8211; The District of Columbia Department of Health.
   
   
   
   Eligible Drug &#8211; Retrovir (AZT), alpha interferon, aerosolized
   pentarnadine, or another drug that is approved by the U.S. Food and Drug
   Administration for therapeutic treatment of persons with HIV/AIDS or related
   illnesses and that is certified for inclusion in this program in a notice
   published in the D.C. Register.
   
   
   
   Insurance Co-Payment &#8211; Any portion of the cost of the eligible drug
   expected to be paid by the patient under the terms of his or her health
   insurance policy or other third-party coverage agreement, including the amount
   of any insurance deductible directly associated with the purchase of an
   eligible drug.
   
   
   
   Insured Applicant &#8211; An applicant for financial assistance under this
   program who has existing health insurance coverage, or other form of insurance
   or third-party payment assistance, for the purchase of an eligible drug.
   
   
   
   Uninsured Applicant &#8211; An applicant for financial assistance under this
   program who has no existing health insurance coverage, or other form of
   insurance or third-party payment assistance for health care needs, and who is
   not approved for assistance under the District of Columbia Medicaid Program.
   For purposes of this chapter, an individual whose existing insurance provides
   no coverage for the purchase of an eligible drug shall be considered
   uninsured.
   
   
   
   	SOURCE: Final Rulemaking published at 36 DCR 4935, 4939 (July 14, 1989); as
   Final Rulemaking published at 54 DCR 2360 (March 16, 2007).
